Krilogy Financial LLC purchased a new position in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 13,785 shares of the company’s stock, valued at approximately $635,000.
Several other hedge funds have also made changes to their positions in DOCU. EverSource Wealth Advisors LLC boosted its position in Docusign by 15.1% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,229 shares of the company’s stock valued at $89,000 after purchasing an additional 161 shares during the period. Smartleaf Asset Management LLC lifted its stake in Docusign by 8.2% in the second quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock valued at $166,000 after buying an additional 165 shares during the last quarter. Centaurus Financial Inc. lifted its stake in Docusign by 3.4% in the third quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock valued at $402,000 after buying an additional 184 shares during the last quarter. Clearstead Advisors LLC boosted its holdings in shares of Docusign by 12.1% during the third quarter. Clearstead Advisors LLC now owns 1,872 shares of the company’s stock valued at $135,000 after acquiring an additional 202 shares during the period. Finally, True Wealth Design LLC boosted its holdings in shares of Docusign by 105.2% during the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after acquiring an additional 222 shares during the period. Institutional investors own 77.64% of the company’s stock.
Docusign Stock Performance
Shares of NASDAQ DOCU opened at $45.31 on Friday. The stock has a fifty day moving average price of $47.01 and a two-hundred day moving average price of $51.72. The firm has a market cap of $8.65 billion, a P/E ratio of 29.43, a PEG ratio of 1.29 and a beta of 0.92. Docusign Inc. has a 1 year low of $40.16 and a 1 year high of $86.65.
Docusign announced that its Board of Directors has authorized a share buyback program on Tuesday, March 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to purchase up to 21% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its stock is undervalued.
Analyst Upgrades and Downgrades
DOCU has been the topic of a number of analyst reports. Weiss Ratings raised shares of Docusign from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, June 3rd. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Friday, June 5th. Morgan Stanley reduced their price objective on Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 18th. Piper Sandler lowered their target price on Docusign from $75.00 to $52.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 18th. Finally, Wells Fargo & Company decreased their price target on Docusign from $60.00 to $55.00 and set an “equal weight” rating for the company in a research note on Friday, June 5th. Three analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $60.27.
Check Out Our Latest Report on Docusign
Insider Activity
In related news, Director Mary Agnes Wilderotter sold 3,000 shares of Docusign stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $48.15, for a total transaction of $144,450.00. Following the transaction, the director directly owned 59,803 shares of the company’s stock, valued at $2,879,514.45. The trade was a 4.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider James P. Shaughnessy sold 12,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $46.83, for a total transaction of $561,960.00. Following the completion of the sale, the insider owned 53,631 shares in the company, valued at approximately $2,511,539.73. This trade represents a 18.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 64,695 shares of company stock valued at $3,006,682 over the last quarter. Insiders own 0.59% of the company’s stock.
Docusign Company Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
